Status:
COMPLETED
Basic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD)
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
ADHD
Eligibility:
All Genders
6-17 years
Phase:
PHASE4
Brief Summary
Children between 6-17 are evaluated for ADHD and and a blood sample is obtained for DNA extraction. If eligible, they participate in a 4 week, double blind, placebo controlled trial with weekly switch...
Eligibility Criteria
Inclusion
- 6-17 DSM IV criteria for ADHD Parents willing to complete measures
Exclusion
- Mental retardation psychoses seizure disorder
Key Trial Info
Start Date :
December 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2004
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00663442
Start Date
December 1 1999
End Date
November 1 2004
Last Update
April 22 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HALP Clinic, University of Illinois at CHicago
Chicago, Illinois, United States, 60608